desmethylsertraline has been researched along with 1-hydroxymethylmidazolam in 1 studies
Studies (desmethylsertraline) | Trials (desmethylsertraline) | Recent Studies (post-2010) (desmethylsertraline) | Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) |
---|---|---|---|---|---|
56 | 8 | 9 | 163 | 46 | 49 |
Protein | Taxonomy | desmethylsertraline (IC50) | 1-hydroxymethylmidazolam (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 10 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Binkley, SN; Ring, BJ; Roskos, L; Wrighton, SA | 1 |
1 other study(ies) available for desmethylsertraline and 1-hydroxymethylmidazolam
Article | Year |
---|---|
Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.
Topics: 1-Naphthylamine; Catalysis; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |